Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
KHTRF
Primary Symbol:
T.GUD
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Post by
EbbFlow88
on Aug 13, 2024 10:23am
Stifel analyst Justin Keywood Upgrade to Buy @ $6.75
“Knight is a specialty pharma company with 90 per cent of sales tied to the LATAM market. We have rated Knight a HOLD, since 2022 with a LATAM discount factored in, impacting investor sentiment and
...more
(155)
•••
longrun86
X
View Profile
View Bullboard History
Comment by
longrun86
on Aug 09, 2024 2:02pm
RE:RE:Q2/24 Comments
I think that product pricing is a big driver but the other drivers are certainly Fx as well as manufacturing & logistics costs. I think there is another few % that could be extracted by increasing
...more
QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp
posted Nov 25, 2024 9:00am by
Q Precious & Battery Metals Corp.
-
|
The Company is pleased to discover that their Lorrain claims are now within the new and exciting exploration for hydrogen in the Ville-Marie, Lorrainville and Béarn region of Quebec. The region has undergone a claim staking rush following the ...read more
(6)
•••
curiousj
X
View Profile
View Bullboard History
Comment by
curiousj
on Aug 09, 2024 8:33am
RE:Q2/24 Comments
I'm assuming Fx/pricing helped due to GM hitting 48% vs 47%, do you have a view on pricing and GM% potential for new launches?
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Post by
gudisgood
on Aug 09, 2024 3:45am
Q2/24 Comments
I liked the report and the earnings call: + Meaningful increase of guidance -> good progress with sales. + Speeding up the pipeline. + Relationship with the Brazilian government (nice to hear!). +
...more
(3216)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Aug 08, 2024 11:15am
Knight Therapeutics Reports Second Quarter 2024
MONTREAL, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan- American (ex-US) specialty pharmaceutical company, today reported
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 08, 2024 7:30am
New Press Release - Knight Therapeutics Reports Second Quarter 2024
Achieved Record Revenues & Increased 2024 Revenue Guidance MONTREAL, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan- American (ex-US) specialty pharmaceutical company, today reported financial results for its second quarter ended...
read article.
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Aug 02, 2024 4:10pm
RE:RE:RE:CPH acquired global rights to lice & scabies treatment
OMG here is another winner who bought at $10 in 2014. Not bad he/she need a 50% increase for par but not counting the opportunity loss.
(8)
•••
wofats
X
View Profile
View Bullboard History
Comment by
wofats
on Aug 01, 2024 11:48am
RE:RE:CPH acquired global rights to lice & scabies treatment
You did mean except for this one over the last 3 years if you were astute enough to buy between Dec.2020 and Dec2023. Just sayin . I do remember you posting you not own any Knight though .
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 01, 2024 7:30am
New Press Release - Notice of Knight Therapeutics' Second Quarter 2024 Results Conference Call
MONTREAL, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its second quarter 2024 financial results on Thursday, August 8, 2024 prior to market opening. Following the release, Knight...
read article.
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Aug 01, 2024 7:09am
RE:CPH acquired global rights to lice & scabies treatment
GoldInvestors investments has returned huge losses and no gold for 11 years
(3)
•••
Snowball2024
X
View Profile
View Bullboard History
Comment by
Snowball2024
on Jul 29, 2024 8:37pm
RE:CPH acquired global rights to lice & scabies treatment
I don't see GUD involved with them. IMO. GUD has to get volume in Mexico and Canada.
(17)
•••
GoldenInvestor
X
View Profile
View Bullboard History
Post by
GoldenInvestor
on Jul 29, 2024 3:40pm
CPH acquired global rights to lice & scabies treatment
no generic alternative to these dermatology products. Will our GUD global distribution netwok be able to help here? CPH up 25%. Who is the chair here? opportunities?
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jul 21, 2024 5:36pm
RE GUF
All investors who have come and bought this stock with entusiasm all have sold in desperations. This company at one time had nearly 800 millions in cash. Why MNGT and the BOD remains the same after so
...more
(127)
•••
Catscratch
X
View Profile
View Bullboard History
Comment by
Catscratch
on Jul 20, 2024 9:41am
RE:Value Investors Club Write-up
Thanks for sharing. They have bought back a lot of stock recently. I'd like to see Knight initiate a modest and growing base dividend... they will have a lot of excess cash as their
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income